LENSAR, Inc. (LNSR)

Market Cap	120.76M
Revenue (ttm)	59.14M
Net Income (ttm)	-51.52M
Shares Out	11.94M
EPS (ttm)	-4.35
PE Ratio	n/a
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	45,931
Open	10.31
Previous Close	10.25
Day's Range	10.10 - 10.48
52-Week Range	7.00 - 17.31
Beta	0.65
Analysts	Hold
Price Target	15.00 (+48.22%)
Earnings Date	Nov 6, 2025

About LNSR

LENSAR, Inc., a commercial-stage medical device company, focuses on designing, developing, and marketing laser system for the treatment of cataracts and the management of pre-existing or surgically induced corneal astigmatism in the United System. The company offers LENSAR Laser System which incorporates a range of proprietary technologies designed to assist the surgeon in obtaining visual outcomes by providing imaging, procedure planning, design, and precision. It also provides ALLY Robotic Cataract Laser System, a compact cataract treatment s...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2004
• Employees: 140
• Stock Exchange: NASDAQ
• Ticker Symbol: LNSR
• Website: https://www.lensar.com

Financial Performance

In 2024, LENSAR's revenue was $53.49 million, an increase of 26.87% compared to the previous year's $42.16 million. Losses were -$31.40 million, 118.3% more than in 2023.

Analyst Summary

According to one analyst, the rating for LNSR stock is "Hold" and the 12-month stock price target is $15.0.

Price Target

$15.0

(48.22% upside)

Analyst Consensus: Hold